Corey S. Goodman, 10% Owner at Checkmate Pharmaceuticals, Inc. (CMPI), sold 263,300 shares at $10.45 ($2.8M) on 2022-05-13, disclosed to the SEC on 2022-05-17.
Open-market sale of $2.8M CMPI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.45 | 35,850 | $375K | 13.6% |
| 2 | $10.45 | 35,850 | $375K | 13.6% |
| 3 | $10.45 | 95,800 | $1.0M | 36.4% |
| 4 | $10.45 | 95,800 | $1.0M | 36.4% |
| Total | $10.45 avg | 263,300 | $2.8M | 100% |
| Filing → |
| AKRO | SELL | 2020-03-06 | $1.9M | — | Filing → |
| AKRO | SELL | 2020-02-06 | $4.2M | — | Filing → |
| AKRO | SELL | 2020-01-14 | $10.0M | — | Filing → |